HHS Recovery Act Recipient Reporting Readiness Tool
Step 3. Select A Grant Award
Review the list of awards and select the Award Title link to see the required reporting data.
| DUNS Number | Award Number | Award Title | Agency | Fiscal Year | Issue Date | Funding Amount |
| 069316271 | 3R01HL084302-02S1 | ROLE OF PROLYL HYDROXYLASE OXYGEN-SENSOR IN CARDIOPROTECTION | NIH | 2009 | 07-15-2009 | $ 0 |
| 183710748 | 1C06RR020609-01A1 | EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM: BSB* | NIH | 2010 | 01-18-2010 | $ 6,616,774 |
| 183710748 | 1F31AI084455-01 | EVALUATING ANTIMICROBIAL COMPOUNDS FROM CORAL-ASSOCIATED PSEUDOVIBRIO BACTERIA | NIH | 2009 | 09-07-2009 | $ 38,821 |
| 183710748 | 1P30AA019362-01 | RESEARCH CORE CENTER---NEUROPLASTICITY OF ALCOHOL ADDICTION | NIH | 2009 | 09-17-2009 | $ 384,849 |
| 183710748 | 1P30DA028811-01 | FACULTY RECRUITMENT INTO NEUROBIOLOGY OF ADDICTION RESEARCH CENTER (NARC) | NIH | 2009 | 09-17-2009 | $ 552,002 |
| 183710748 | 1R01AA017756-01 | MECHANISMS OF IN VIVO ETHANOL-INDUCED MITOCHONDRIAL DEPOLARIZATION | NIH | 2009 | 07-16-2009 | $ 366,069 |
| 183710748 | 1R01AG033032-01 | APATHY IN ALZHEIMER'S DISEASE METHYLPHENIDATE TRIAL | NIH | 2009 | 09-16-2009 | $ 740,419 |
| 183710748 | 1R01CA134845-01A1 | RECEPTOR CROSSTALK IN HNSCC METASTATIC PROGRESSION | NIH | 2009 | 06-03-2009 | $ 224,569 |
| 183710748 | 1R01DA026777-01 | A CONTROLLED TRIAL OF N-ACETYLCYSTEINE (NAC) IN CANNABIS DEPENDENT ADOLESCENTS | NIH | 2009 | 07-14-2009 | $ 360,781 |
| 183710748 | 1R01ES016774-01A1 | PESTICIDES, PARAOXONASE AND ALZHEIMER'S DISEASE | NIH | 2009 | 09-15-2009 | $ 405,625 |
| 183710748 | 1R01EY019515-01 | CONE OPSIN-LIGAND INTERACTIONS AND PHOTORECEPTOR HEALTH | NIH | 2009 | 06-02-2009 | $ 368,750 |
| 183710748 | 1R01HL094517-01A1 | POST-SYNTHETIC PROCOLLAGEN PROCESSING IN LOAD-INDUCED LEFT VENTRICULAR REMODELING | NIH | 2009 | 08-28-2009 | $ 368,750 |
| 183710748 | 1R03AI079248-01A1 | THE ROLE OF BETA-ARRESTINS 1 AND 2 IN RHEUMATOID ARTHRITIS | NIH | 2009 | 08-07-2009 | $ 73,750 |
| 183710748 | 1R03AR056767-01 | CAVEOLIN-1 REGULATION OF ALTERED FUNCTIONS OF SCLERODERMA FIBROCYTES | NIH | 2009 | 07-15-2009 | $ 73,750 |
| 183710748 | 1R03DE019506-01A1 | ROLE OF CILIA IN MAMMALIAN TOOTH PATTERNING | NIH | 2009 | 09-16-2009 | $ 110,625 |
| 183710748 | 1R03ES017298-01 | PERFLUOROOCTANE SULFONATE (PFOS) AFFECTS 1GM PRODUCTION VIA IL-2 | NIH | 2009 | 05-18-2009 | $ 63,000 |
| 183710748 | 1R03HD060265-01A1 | GROWTH AND CARCINOGENIC POTENTIAL IN THE POSTNATAL MAMMARY GLAND | NIH | 2009 | 08-24-2009 | $ 73,750 |
| 183710748 | 1R21AG032083-01A1 | FEEDING IN ELDERLY LATE-STAGE DEMENTIA: THE FIELD TRIAL | NIH | 2009 | 05-18-2009 | $ 171,696 |
| 183710748 | 1R21AI078098-01 | IN VIVO-INDUCTION OF CANDIDA ALBICANS MORPHOGENESIS | NIH | 2009 | 08-28-2009 | $ 220,198 |
| 183710748 | 1R21AI081640-01A1 | REV-DEPENDENT NUCLEAR EXPORT OF RNA | NIH | 2009 | 08-07-2009 | $ 202,790 |
| 183710748 | 1R21CA137725-01 | ISOLATION AND CHARACTERIZATION OF PROSTRATE ANTIGEN SPECIFIC HIGH AFFINITY TCR | NIH | 2009 | 05-18-2009 | $ 162,250 |
| 183710748 | 1R21DA027055-01 | INFRALIMBIC REGULATION OF MEMORY CONSOLIDATION OF EXTINCTION OF COCAINE-SEEKING | NIH | 2009 | 05-18-2009 | $ 177,250 |
| 183710748 | 1R21DC010480-01A1 | RESPIRATORY PHASE TRAINING EFFECTS ON SWALLOW IMPAIRMENT IN OROPHARYNGEAL CANCER | NIH | 2009 | 08-07-2009 | $ 221,250 |
| 183710748 | 1R21NS063183-01A1 | ATHEROGENIC INDUCTION OF NEUROINFLAMMATION | NIH | 2009 | 05-13-2009 | $ 221,156 |
| 183710748 | 1R21NS067112-01 | DEVELOPMENT OF LIPID THERAPEUTICS FOR FATTY ACID 2-HYDROXYLASE DEFICIENCY | NIH | 2009 | 09-28-2009 | $ 179,625 |
| 183710748 | 1R56ES017453-01A1 | RNS MEDIATED REGULATION OF PROTEIN DISULFIDE ISOMERASE IN NEURONAL CELLS | NIH | 2010 | 05-29-2010 | $ 107,827 |
| 183710748 | 1RC1AA019019-01 | TREATMENT IMPLICATIONS OF TRAUMA MEMORY MODULATION FOR PTSD & ALCOHOL DEPENDENCE | NIH | 2009 | 09-30-2009 | $ 390,413 |
| 183710748 | 1RC1AA019138-01 | GENE EXPRESSION PROFILING IN A MOUSE MODEL OF ETHANOL DEPENDENCE AND DRINKING | NIH | 2009 | 09-30-2009 | $ 497,615 |
| 183710748 | 1RC1MD004405-01 | CRITICAL CARE EXCELLENCE IN SEPSIS AND TRAUMA (CREST) | NIH | 2009 | 09-22-2009 | $ 499,916 |
| 183710748 | 1RC1MH088950-01 | COST-EFFECTIVENESS OF HIV-RELATED MENTAL HEALTH INTERVENTIONS | NIH | 2009 | 09-25-2009 | $ 298,708 |
| 183710748 | 1S10RR026904-01 | THERMO TSQ QUANTUM ACCESS MASS SPECTROMETER | NIH | 2010 | 05-06-2010 | $ 256,779 |
| 183710748 | 1S10RR027777-01 | FLUOROMETRIC IMAGING PLATE READER (FLIPRTETRA) | NIH | 2010 | 03-04-2010 | $ 499,800 |
| 183710748 | 2R01CA083672-09A1 | TARGETING EARLY ACTIVATED T CELLS FOR ADOPTIVE THERAPY | NIH | 2009 | 06-17-2009 | $ 259,295 |
| 183710748 | 2R01HD046820-06A1 | INTERMUSCULAR COORDINATION OF HEMIPARETIC WALKING | NIH | 2010 | 09-07-2010 | $ 363,805 |
| 183710748 | 3G08LM009624-02S1 | CAROLINAS CONVERSATIONS: A MULTIETHNIC DIGITAL CORPUS OF SPEECH FOR OLDER PERSONS | NIH | 2009 | 09-15-2009 | $ 65,010 |
| 183710748 | 3K01DK070054-05S1 | CROSSTALK AMONG GROWTH FACTORS, ADAMS AND INTEGRINS | NIH | 2010 | 12-16-2009 | $ 54,000 |
| 183710748 | 3K08CA103858-05S1 | AN ANIMAL MODEL FOR KAPOSI'S SARCOMA | NIH | 2009 | 09-16-2009 | $ 49,628 |
| 183710748 | 3K08DK080944-02S1 | ANGIOTENSIN METABOLITE FORMATION BY PODOCYTES: IMPLICATIONS IN GLOMERULAR INJURY | NIH | 2010 | 04-01-2010 | $ 53,888 |
| 183710748 | 3K23DC008787-02S1 | AUDITORY TEMPORAL PROCESSING IN THE AGING EAR AND BRAIN | NIH | 2009 | 07-15-2009 | $ 52,719 |
| 183710748 | 3K24CA120494-03S1 | K24 MID-CAREER INVESTIGATOR AWARD IN PATIENT-ORIENTED RESEARCH | NIH | 2009 | 09-14-2009 | $ 107,775 |
| 183710748 | 3P01AG023630-05S1 | DUAL-HIT HYPOTHESIS OF AGING-RELATED DA DYSFUNCTION | NIH | 2009 | 09-09-2009 | $ 106,259 |
| 183710748 | 3P20RR016434-09S1 | SC COBRE FOR DEVELOPMENTALLY BASED CARDIOVASCULAR DISEASES | NIH | 2009 | 07-10-2009 | $ 281,041 |
| 183710748 | 3P20RR016434-09S2 | SC COBRE FOR DEVELOPMENTALLY BASED CARDIOVASCULAR DISEASES | NIH | 2009 | 09-01-2009 | $ 796,712 |
| 183710748 | 3P20RR017677-08S1 | COBRE IN LIPIDOMICS AND PATHOBIOLOGY | NIH | 2009 | 09-15-2009 | $ 927,220 |
| 183710748 | 3P20RR017696-08S1 | SOUTH CAROLINA COBRE FOR ORAL HEALTH RESEARCH | NIH | 2009 | 08-25-2009 | $ 651,170 |
| 183710748 | 3P20RR017696-08S2 | SOUTH CAROLINA COBRE FOR ORAL HEALTH RESEARCH | NIH | 2009 | 09-09-2009 | $ 587,298 |
| 183710748 | 3P30CA138313-01S3 | MEDICAL UNIVERSITY OF SOUTH CAROLINA - CANCER CENTER SUPPORT GRANT | NIH | 2009 | 09-22-2009 | $ 2,548,679 |
| 183710748 | 3P50AA010761-14S1 | ALCOHOL RESEARCH CENTER - TREATMENT AND IMPLICATIONS | NIH | 2009 | 08-17-2009 | $ 67,458 |
| 183710748 | 3P50DA015369-07S2 | NEUROBIOLOGY OF ADDICTION RESEARCH CENTER | NIH | 2009 | 06-17-2009 | $ 75,638 |
| 183710748 | 3P50DC000422-21A1S1 | EXPERIMENTAL AND CLINICAL STUDIES OF PRESBYACUSIS | NIH | 2009 | 07-15-2009 | $ 348,432 |
| 183710748 | 3R01AA009986-14S1 | ETHANOL SENSITIVITY OF NATIVE AND CLONED NMDA RECEPTORS | NIH | 2009 | 07-14-2009 | $ 94,031 |
| 183710748 | 3R01AA010983-12A1S1 | ACTIN DYNAMICS AND SPINE REMODELING IN ETHANOL-INDUCED PLASTICITY | NIH | 2010 | 02-10-2010 | $ 71,010 |
| 183710748 | 3R01AI080421-01S1 | ROLE OF P38 MAPK IN HSC SELF-RENEWAL AND RADIATION-INDUCED BONE MARROW INJURY | NIH | 2009 | 06-03-2009 | $ 6,071 |
| 183710748 | 3R01CA104947-03S1 | TCR AFFINITY AND THERAPEUTIC EFFICACY OF T CELLS | NIH | 2009 | 08-31-2009 | $ 299,698 |
| 183710748 | 3R01CA104947-03S2 | TCR AFFINITY AND THERAPEUTIC EFFICACY OF T CELLS | NIH | 2009 | 09-30-2009 | $ 122,881 |
| 183710748 | 3R01CA105069-05S1 | DNA REPAIR, SKIN CANCER AND OVERALL CANCER RISK | NIH | 2009 | 09-16-2009 | $ 198,711 |
| 183710748 | 3R01CA109254-04S1 | DRUG-INDUCED DESTABILIZATION OF BCL-2 MRNA | NIH | 2009 | 08-31-2009 | $ 139,225 |
| 183710748 | 3R01CA119079-03S1 | MECHANISMS OF CELL DEATH AFTER PHOTODYNAMIC THERAPY | NIH | 2009 | 08-31-2009 | $ 91,564 |
| 183710748 | 3R01CA122023-03S1 | CANCER THERAPY-INDUCED LONG-TERM BONE MARROW INJURY | NIH | 2009 | 08-31-2009 | $ 57,990 |
| 183710748 | 3R01CA129560-01A2S1 | DISRUPTION OF HLA CLASS II-MEDIATED IMMUNE RECOGNITION OF B-CELL LYMPHOMAS | NIH | 2009 | 06-05-2009 | $ 15,128 |
| 183710748 | 3R01DA023188-02S1 | D-CYCLOSERINE FACILITATION OF COCAINE-CUE EXTINCTION | NIH | 2009 | 09-21-2009 | $ 567,200 |
| 183710748 | 3R01DC000184-28S1 | AUDITORY ANALYSIS AND SPEECH RECOGNITION | NIH | 2009 | 07-15-2009 | $ 137,625 |
| 183710748 | 3R01DC007613-04S2 | MECHANISMS OF SENSORY HAIR CELL DEATH AND SURVIVAL | NIH | 2009 | 07-15-2009 | $ 5,000 |
| 183710748 | 3R01DE018290-04S2 | NEGATIVE REGULATION OF INNATE IMMUNE RESPONSES THROUGH MAPK PHOSPHATASES | NIH | 2009 | 09-18-2009 | $ 99,675 |
| 183710748 | 3R01DK002001-48A1S1 | FACTORS THAT MODIFY INSULIN ACTION | NIH | 2010 | 12-28-2009 | $ 95,184 |
| 183710748 | 3R01DK037034-24S1 | LIVER PRESERVATION FOR TRANSPLANTATION | NIH | 2010 | 02-16-2010 | $ 66,473 |
| 183710748 | 3R01DK052448-11S1 | MECHANISMS OF REGULATION OF NHE-1 | NIH | 2009 | 08-14-2009 | $ 100,001 |
| 183710748 | 3R01DK054388-12S1 | MECHANISM OF ACTION OF A MAJOR FOLATE ENZYME | NIH | 2010 | 02-04-2010 | $ 96,518 |
| 183710748 | 3R01DK055524-11A2S1 | TYROSINE KINASES IN G PROTEIN MEDIATED SIGNALING | NIH | 2010 | 01-15-2010 | $ 150,899 |
| 183710748 | 3R01DK062596-08S1 | A PROGRAM TO INCREASE LIVING DONATIONS IN AFRICAN AMERICANS | NIH | 2010 | 05-28-2010 | $ 146,093 |
| 183710748 | 3R01DK070844-04S1 | TRANSPLANTATION OF REDUCED-SIZE FATTY LIVERS | NIH | 2010 | 02-16-2010 | $ 31,775 |
| 183710748 | 3R01DK073270-03S1 | PROLACTIN GENE EXPRESSION DYNAMICS AND MAMMOTROPE FUNCTION | NIH | 2010 | 03-12-2010 | $ 98,751 |
| 183710748 | 3R01DK081352-02S1 | BIOMARKERS OF VASCULAR DISEASE PROGRESSION IN TYPE 1 DIABETES MELLITUS | NIH | 2009 | 09-21-2009 | $ 410,125 |
| 183710748 | 3R01ES016197-02S1 | INTEGRATING MICROBIAL BIOSTIMULATION AND ELECTROLYTIC AERATION TO DEGRADE POPS | NIH | 2009 | 09-07-2009 | $ 287,050 |
| 183710748 | 3R01EY009741-17S1 | ADENOSINE AGONISTS: POTENTIAL ANTIGLAUCOMA AGENTS | NIH | 2009 | 08-12-2009 | $ 281,462 |
| 183710748 | 3R01GM027673-28S1 | THE ROLE OF EICOSANOIDS IN SHOCK | NIH | 2009 | 09-24-2009 | $ 369,050 |
| 183710748 | 3R01GM049264-17S1 | MECHANISM OF TERMINATION OF DNA REPLICATION | NIH | 2010 | 01-15-2010 | $ 174,339 |
| 183710748 | 3R01GM062887-08S1 | SPHINGOSINE PHOSPHATE ROLE IN INFLAMMATION | NIH | 2009 | 09-30-2009 | $ 118,360 |
| 183710748 | 3R01GM066861-07S1 | MOLECULAR TARGETS IN PEPTIDOGLYCAN SYNTHESIS | NIH | 2009 | 09-22-2009 | $ 177,917 |
| 183710748 | 3R01GM081054-03S1 | NOREPINEPHRINE TRANSPORT REGULATION BY PHOSPHORYLATION | NIH | 2009 | 09-30-2009 | $ 57,290 |
| 183710748 | 3R01GM082981-01A2S1 | GENERATION AND FUNCTION OF VARIABLE PRENYL PROTEIN PROCESSING | NIH | 2009 | 07-15-2009 | $ 273,992 |
| 183710748 | 3R01HD047511-04S1 | ESTABLISHING THE VITAMIN D REQUIREMENTS DURING LACTATION | NIH | 2009 | 09-28-2009 | $ 72,682 |
| 183710748 | 3R01HL029397-25A2S1 | REGULATION AND FUNCTION OF TISSUE KALLIKREIN | NIH | 2009 | 05-29-2009 | $ 51,373 |
| 183710748 | 3R01HL043707-19S1 | ROLE AND REGULATION OF PROTEIN KINASE C ISOENZYMES | NIH | 2009 | 05-29-2009 | $ 10,950 |
| 183710748 | 3R01HL057952-10S1 | ENDOTHELIN RECEPTORS AND PROGRESSION TO HEART FAILURE | NIH | 2009 | 07-15-2009 | $ 366,378 |
| 183710748 | 3R01HL079274-04S1 | SPHINGOLIPID SIGNALING INDUCED BY LDL IMMUNE COMPLEXES | NIH | 2009 | 07-15-2009 | $ 215,216 |
| 183710748 | 3R01LM009153-02S1 | AUTOMATIC LITERATURE-BASED PROTEIN ANNOTATION | NIH | 2009 | 05-28-2009 | $ 39,294 |
| 183710748 | 3R01LM009153-03S1 | AUTOMATIC LITERATURE-BASED PROTEIN ANNOTATION | NIH | 2009 | 09-01-2009 | $- 14,785 |
| 183710748 | 3R01MH081056-03S1 | WEB-BASED INTERVENTION FOR DISASTER-AFFECTED ADOLESCENTS AND FAMILIES | NIH | 2010 | 09-28-2010 | $ 213,824 |
| 183710748 | 3R01NS060807-02S2 | LIPID HYDROXYLATION IN GLIAL CELL SIGNALING AND MYELINATION | NIH | 2009 | 08-13-2009 | $ 140,131 |
| 183710748 | 3R03AI079248-02S1 | THE ROLE OF BETA-ARRESTINS 1 AND 2 IN RHEUMATOID ARTHRITIS | NIH | 2010 | 08-02-2010 | $ 52,947 |
| 183710748 | 3R25GM072643-05S1 | MUSC MINORITY STUDENT DEVELOPMENT PROGRAM | NIH | 2009 | 09-09-2009 | $ 71,034 |
| 183710748 | 3T32GM008716-11S1 | TRAINING PROGRAM FOR MEDICAL SCIENTISTS | NIH | 2009 | 07-31-2009 | $ 157,928 |
| 183710748 | 3T32GM074934-05S1 | BIOSTATISTICS TRAINING FOR BASIC BIOMEDICAL RESEARCH | NIH | 2009 | 08-03-2009 | $ 74,418 |
| 183710748 | 3U01AA014095-07S1 | ETHANOL DEPENDENCE AND STRESS EFFECTS ON ETHANOL DRINKING: ROLE OF CRF | NIH | 2009 | 09-30-2009 | $ 493,255 |
| 183710748 | 3U01AA014095-07S2 | ETHANOL DEPENDENCE AND STRESS EFFECTS ON ETHANOL DRINKING: ROLE OF CRF | NIH | 2009 | 07-15-2009 | $ 42,869 |
| 183710748 | 5F31AI084455-02 | EVALUATING ANTIMICROBIAL COMPOUNDS FROM CORAL-ASSOCIATED PSEUDOVIBRIO BACTERIA | NIH | 2010 | 08-10-2010 | $ 26,335 |
| 183710748 | 5P30AA019362-02 | RESEARCH CORE CENTER---NEUROPLASTICITY OF ALCOHOL ADDICTION | NIH | 2010 | 08-25-2010 | $ 380,864 |
| 183710748 | 5P30DA028811-02 | FACULTY RECRUITMENT INTO NEUROBIOLOGY OF ADDICTION RESEARCH CENTER (NARC) | NIH | 2010 | 08-13-2010 | $ 325,834 |
| 183710748 | 5R01AA017756-02 | MECHANISMS OF IN VIVO ETHANOL-INDUCED MITOCHONDRIAL DEPOLARIZATION | NIH | 2010 | 07-29-2010 | $ 368,750 |
| 183710748 | 5R01AG033032-02 | APATHY IN ALZHEIMER'S DISEASE METHYLPHENIDATE TRIAL | NIH | 2010 | 07-30-2010 | $ 709,569 |
| 183710748 | 5R01CA083672-10 | TARGETING EARLY ACTIVATED T CELLS FOR ADOPTIVE THERAPY | NIH | 2010 | 07-29-2010 | $ 259,295 |
| 183710748 | 5R01CA134845-02 | RECEPTOR CROSSTALK IN HNSCC METASTATIC PROGRESSION | NIH | 2010 | 07-01-2010 | $ 224,569 |
| 183710748 | 5R01DA026777-02 | A CONTROLLED TRIAL OF N-ACETYLCYSTEINE (NAC) IN CANNABIS DEPENDENT ADOLESCENTS | NIH | 2010 | 06-18-2010 | $ 360,845 |
| 183710748 | 5R01ES016774-02 | PESTICIDES, PARAOXONASE AND ALZHEIMER'S DISEASE | NIH | 2010 | 07-13-2010 | $ 405,625 |
| 183710748 | 5R01EY019515-02 | CONE OPSIN-LIGAND INTERACTIONS AND PHOTORECEPTOR HEALTH | NIH | 2010 | 06-30-2010 | $ 368,750 |
| 183710748 | 5R01HL094517-02 | POST-SYNTHETIC PROCOLLAGEN PROCESSING IN LOAD-INDUCED LEFT VENTRICULAR REMODELING | NIH | 2010 | 08-28-2010 | $ 368,750 |
| 183710748 | 5R03AI079248-02 | THE ROLE OF BETA-ARRESTINS 1 AND 2 IN RHEUMATOID ARTHRITIS | NIH | 2010 | 07-22-2010 | $ 73,750 |
| 183710748 | 5R03AR056767-02 | CAVEOLIN-1 REGULATION OF ALTERED FUNCTIONS OF SCLERODERMA FIBROCYTES | NIH | 2010 | 06-23-2010 | $ 73,750 |
| 183710748 | 5R03DE019506-02 | ROLE OF CILIA IN MAMMALIAN TOOTH PATTERNING | NIH | 2010 | 08-02-2010 | $ 110,625 |
| 183710748 | 5R03HD060265-02 | GROWTH AND CARCINOGENIC POTENTIAL IN THE POSTNATAL MAMMARY GLAND | NIH | 2010 | 08-20-2010 | $ 73,750 |
| 183710748 | 5R21AG032083-02 | FEEDING IN ELDERLY LATE-STAGE DEMENTIA: THE FIELD TRIAL | NIH | 2010 | 04-30-2010 | $ 148,147 |
| 183710748 | 5R21AI078098-02 | IN VIVO-INDUCTION OF CANDIDA ALBICANS MORPHOGENESIS | NIH | 2010 | 08-02-2010 | $ 183,323 |
| 183710748 | 5R21AI081640-02 | REV-DEPENDENT NUCLEAR EXPORT OF RNA | NIH | 2010 | 07-08-2010 | $ 202,790 |
| 183710748 | 5R21CA137725-02 | ISOLATION AND CHARACTERIZATION OF PROSTRATE ANTIGEN SPECIFIC HIGH AFFINITY TCR | NIH | 2010 | 05-11-2010 | $ 194,700 |
| 183710748 | 5R21DA027055-02 | INFRALIMBIC REGULATION OF MEMORY CONSOLIDATION OF EXTINCTION OF COCAINE-SEEKING | NIH | 2010 | 05-19-2010 | $ 13,275 |
| 183710748 | 5R21DC010480-02 | RESPIRATORY PHASE TRAINING EFFECTS ON SWALLOW IMPAIRMENT IN OROPHARYNGEAL CANCER | NIH | 2010 | 07-16-2010 | $ 184,375 |
| 183710748 | 5R21NS063183-02 | ATHEROGENIC INDUCTION OF NEUROINFLAMMATION | NIH | 2010 | 04-12-2010 | $ 184,356 |
| 183710748 | 5R21NS067112-02 | DEVELOPMENT OF LIPID THERAPEUTICS FOR FATTY ACID 2-HYDROXYLASE DEFICIENCY | NIH | 2010 | 08-17-2010 | $ 184,375 |
| 183710748 | 5RC1AA019019-02 | TREATMENT IMPLICATIONS OF TRAUMA MEMORY MODULATION FOR PTSD & ALCOHOL DEPENDENCE | NIH | 2010 | 08-25-2010 | $ 408,057 |
| 183710748 | 5RC1AA019138-02 | GENE EXPRESSION PROFILING IN A MOUSE MODEL OF ETHANOL DEPENDENCE AND DRINKING | NIH | 2010 | 08-10-2010 | $ 497,513 |
| 183710748 | 5RC1MD004405-02 | CRITICAL CARE EXCELLENCE IN SEPSIS AND TRAUMA (CREST) | NIH | 2010 | 08-18-2010 | $ 498,237 |
| 183710748 | 5RC1MH088950-02 | COST-EFFECTIVENESS OF HIV-RELATED MENTAL HEALTH INTERVENTIONS | NIH | 2010 | 08-05-2010 | $ 261,683 |
| 183710748 | 7R01EB007656-03 | QUANTITATIVE MRI OF MICROSTRUCTURE AND IRON HOMEOSTASIS IN ADHD BRAIN | NIH | 2011 | 12-06-2010 | $ 476,102 |
| 183710748 | 7RC1HL100556-02 | NOVEL CHAPERONE MECHANISM FOR PLATELET DISORDER | NIH | 2010 | 08-30-2010 | $ 500,000 |
| 183710748 | D5AHP19900 | ARRA - TRAINING IN PRIMARY CARE MEDICINE AND DENTISTRY: ADMINISTRATIVE ACADEMIC UNITS | HRSA | 2010 | 08-20-2010 | $ 170,000 |
| 183710748 | D5BHP20435 | ARRA - TRAINING IN PRIMARY CARE MEDICINE AND DENTISTRY: PHYSICIAN ASSISTANT TRAINING IN PRIMARY CARE | HRSA | 2010 | 09-03-2010 | $ 1,630,281 |
| 183710748 | D76HP20716 | ARRA - EQUIPMENT TO ENHANCE TRAINING FOR HEALTH PROFESSIONALS | HRSA | 2010 | 09-04-2010 | $ 281,230 |
| 183710748 | D76HP20775 | ARRA - EQUIPMENT TO ENHANCE TRAINING FOR HEALTH PROFESSIONALS | HRSA | 2010 | 09-02-2010 | $ 299,901 |
| 183710748 | R01DC007613-4-003 | MECHANISMS OF SENSORY HAIR CELL DEATH AND SURVIVAL | NIH | 2011 | 04-18-2011 | $ 162,416 |
| 183710748 | R01DK052448-11-001 | MECHANISMS OF REGULATION OF NHE-1 | NIH | 2010 | 09-27-2010 | $- 44,100 |
| 183710748 | R01LM009153-3-006 | AUTOMATIC LITERATURE-BASED PROTEIN ANNOTATION | NIH | 2010 | 09-30-2010 | $ 138,415 |
| 183710748 | R03DC008403-3-006 | THROAT CLEARING, COUGHING, AND ALTERNATIVE BEHAVIORS | NIH | 2010 | 01-27-2010 | $ 39,530 |
| 183710748 | R03ES017298-1-001 | PERFLUOROOCTANE SULFONATE (PFOS) AFFECTS 1GM PRODUCTION VIA IL-2 | NIH | 2010 | 11-10-2009 | $- 63,000 |
| 183710748 | R18HS019339-2-001 | DISSEMINATING BREAST CANCER PREVENTION TO AFRICAN AMERICAN WOMEN | AHRQ | 2012 | 08-14-2012 | $ 928,579 |
| 183710748 | R21DA024401-3-001 | EXPLORING THE NEUROBIOLOGICAL RESPONSE TO ANTI-DRUG MEDIA MESSAGES WITH FMRI | NIH | 2011 | 03-21-2011 | $ 371,002 |
To continue, click on the Award Title in the list above to obtain detailed data about a specific Award.
The Award Detail screen should display with the data for that award that is available for reporting to FederalReporting.gov.
DISCLAIMER
The data contained in the HHS Recipient Readiness Tool reflects the best available data for HHS grant programs that are subject to Recovery Act Recipient Reporting. Please note that according to OMB supplemental guidance recipients are not required to report on awards less than $25,000 on FederalReporting.gov. For a list of programs that must be reported to FederalReporting.gov please visit Appendix 1 of the June 22nd OMB guidance. For additional questions or concerns on reporting requirements for your award please contact your grants management specialist.
Data are refreshed every 24 hours. Awards issued near the end of the reporting period may not be available for 72 hours pending the timeliness of HHS Agency data transmission. If you are unable to locate your data please contact your grants management specialist.
